Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897413 · ClinicalTrials.gov registry record · Phase 1
Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers
A Phase 1 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT03897413 is a Phase 1 study that has completed, run by Shionogi. The registered enrollment target is 15 participants.
The verdict
NCT03897413, a Phase 1 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary objectives of this study were: * To assess the effect of a high-fat diet on the pharmacokinetics (PK) of a 0.75 mg single dose of S-888711 orally administered as 0.25 mg tablets in healthy volunteer adults * To assess the effect of a calcium supplement on the PK of a 0.75 mg single dose of S-888711 orally administered as 0.25 mg tablets in healthy volunteer adults
Interventions
- DRUG S-888711
- DIETARY_SUPPLEMENT Calcium Antacid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-11-06 |
| Est. Completion | 2009-12-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03897413
The ClinicalTrials.gov registry entry for NCT03897413 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which S-888711 is the first listed.
NCT03897413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03897413 about?
NCT03897413 is a clinical study titled "Effect of Food and Calcium on Pharmacokinetics of a Single Dose of S-888711 in Healthy Adult Volunteers". The primary objectives of this study were: * To assess the effect of a high-fat diet on the pharmacokinetics (PK) of a 0.75 mg single dose of S-888711 orally administered as 0.25 mg tablets in healthy volunteer adults * To assess the effect of a calcium supplement on the PK of a 0.75 mg single dose...
What is the current status of trial NCT03897413?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2009-11-06. Estimated completion is 2009-12-23.
What interventions are being tested in trial NCT03897413?
The interventions under investigation include: S-888711 (DRUG), Calcium Antacid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03897413?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.